A Protocol for Venous Thromboembolism Prophylaxis in Elective Spine Surgery: A Retrospective Evaluation of a Single-Center Experience
Open Access
- 3 June 2025
- journal article
- Published by Springer Nature in Cureus
- Vol. 17 (6) , e85297
Abstract
Introduction: Venous thromboembolic (VTE) events include deep vein thrombosis (DVT) and pulmonary embolism (PE). In spine surgery, the risk of VTE events should be weighed against the risk of developing epidural hematoma (EDH). This has made the subject of VTE prophylaxis in spine surgery an ongoing matter of debate in the scientific community. Objective: To present our experience with venous thromboembolism prophylaxis in patients undergoing elective spine surgery and discuss it in the light of the literature. Methods: This was a retrospective review done on all patients who underwent elective spine surgery at our institution from 2019 to 2024 and were prescribed a specified VTE prophylaxis protocol (inpatient enoxaparin and a seven-day course of rivaroxaban following discharge). Patients who underwent spine surgery for non-elective indications, were known to have a malignancy, had a history of VTE, were already on anticoagulant therapy, and/or were non-ambulatory, were excluded. Results: A total of 528 patients were included; 284 (53.78%) patients were males, and 354 (67.04%) surgeries were thoraco-lumbar. Of the 174 (32.95%) surgeries performed on the cervical spine, 105 were anterior discectomies and 69 were laminectomies. The mean age (±SD) was 55.06 years (±14.9). The majority of the included patients were overweight/obese; 447 patients (84.65%). Of all the patients, 452 (85.6%) started to ambulate on Day 1, and the mean (±SD) length of hospital stay was comparable for patients undergoing cervical and thoracolumbar spine surgeries, 4.6 (±1.3) and 4.8 (±1.6), respectively. None of the patients experienced VTE events, while three (0.56%) developed EDH. Conclusion: The protocol presented in this report is safe and effective in preventing VTE in ambulatory patients undergoing elective spine surgery. Rivaroxaban is a possible option for VTE prophylaxis in patients undergoing elective spine surgery, including procedures involving the cervical spine.Keywords
This publication has 12 references indexed in Scilit:
- Comparison between rivaroxaban versus enoxaparin for venous thromboembolism prophylaxis following spine surgeries, a randomized clinical trialJournal of Clinical Neuroscience, 2022
- Graduated compression stockings for prevention of deep vein thrombosisCochrane Database of Systematic Reviews, 2018
- Comparison of Apixaban and Rivaroxaban for Anticoagulant Effect After Lumbar Spine Surgery: a Single-Center ReportFuture Science OA, 2018
- Risk factors associated with venous thromboembolism in patients undergoing spine surgeryJournal of Neurosurgery: Spine, 2017
- Factors predicting venous thromboembolism after spine surgeryMedicine, 2016
- Comparison of rivaroxaban and parnaparin for preventing venous thromboembolism after lumbar spine surgeryJournal of Orthopaedic Surgery and Research, 2015
- Low-Molecular-Weight Heparin Prophylaxis 24 to 36 Hours After Degenerative Spine SurgerySpine, 2013
- Postoperative Spinal Epidural HematomaSpine, 2010
- An evidence-based clinical guideline for the use of antithrombotic therapies in spine surgeryThe Spine Journal, 2009
- The Prophylactic Use of Inferior Vena Cava Filters in Patients Undergoing High-Risk Spinal SurgeryAnnals of Vascular Surgery, 2005